general-medicine
PREDICT Breast Cancer 5- and 10-year Survival (Bands)
PREDICT Breast (Wishart 2010; version 3, Grootes 2024) estimates overall survival after surgery for early invasive breast cancer and the absolute benefit of adjuvant treatments. It is a survival model with many inputs and cannot be scored here — use the official tool at breast.predict.cam.
References
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Drugs
- Cetuximab · Anti-EGFR Monoclonal Antibody — Head and Neck Cancer
- Cisplatin · Platinum Chemotherapy — Head and Neck Cancer
- Ianalumab (Anti-BAFF — Primary Sjögren's Syndrome) · Anti-BAFF Monoclonal Antibody (B-Cell Survival Factor Inhibitor)
- Dalteparin · Low Molecular Weight Heparin — VTE Treatment / Cancer-Associated Thrombosis
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.